Association for Value-Based Cancer Care (AVBCC)

2023 AVBCC Summit

October 18-20, 2023

New York Athletic Club, New York, NY

The Association for Value-Based Cancer Care (AVBCC) will once again be meeting in person at the New York Athletic Club. The live event will be invitation-only, limiting the number of guests to follow safety guidelines. There will be a virtual simulcast of the entire Summit for those who cannot join us in New York.

The One Conference That Covers It All

Join us for this exclusive invitational forum that provides invaluable time with more than 200 diverse experts representing every stakeholder of the cancer care ecosystem. Nearly 100% of attendees agreed the content, topics, sessions, and information were relevant and up-to-date.

Top Reasons to Participate in the 2023 Summit
- LEARN to stay competitive in the ever-changing field of oncology.
- EXPLORE cutting-edge methodologies you can implement in your company or institution immediately.
- ACCESS timely and accurate information from sources you can rely on.
- GAIN insights from a diverse range of practitioners, pharmacists, payers, policymakers, and other key stakeholders.
- NETWORK with nationally recognized thought leaders.
Registration

LIVE

REQUEST AN INVITE

Click to Get Started

VIRTUAL

REGISTRATION

Click to Get Started

Please Note:
The live event is available on a first come, first served basis due to limited capacity. Sponsors will be guaranteed the opportunity to attend live. The general public is encouraged to request an invite to join and will be notified when accepted.

The AVBCC Summit continues to empower all oncology care professionals to maximize value in cancer care by focusing on clinical, cost, and access issues. Secure your seat at the table today!

Take a look at the exciting lineup for the 2023 Summit! Sessions feature experts and respected faculty from across the field. This is a must-attend event for all stakeholders in the cancer-care value equation. Secure your spot today!

Wednesday, October 18

8:00am - 8:50am	The Future of Value-Based Care and Implications for US Healthcare Moderator: Linde Wilson, MBA Managing Partner, HealthQuest Advisors Faculty: Blair Childs President & CEO, Childs & Associates Digital Healthcare Technology: A Robust Growth Sector Moderator: Stan Kachnowski, PhD, MPA Director, Digital Health Program, Columbia Business School Faculty: Meg Barron Managing Director, Engagement & Outreach Peterson Center on Healthcare Ryan Huey, MD Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, MD Anderson Chevon Rariy, MD Chief Health Officer, Oncology Care Partners Christopher Merlan Chief Digital Officer & EVP, ASCO Warranties and Reinsurance to Manage Risk: Pharma and Provider Solutions Moderator: John Doyle, DrPH, MPH Group VP, Exponent Faculty: Scott Kornhauser CEO, KlearTrust Barbara McAneny, MD Past President, American Medical Association; Chair, National Cancer Care Alliance; CEO, New Mexico Cancer Center Brian Kern, Esq. Partner, Arcadia Brooks Wildasin Co-Founder & Chief Underwriting Officer, OutcomeRx Matt Hurlburt, MHA Head, Global Healthcare Innovation Center, Pfizer End of Life: Have We Made Improvements to this Legacy Issue? Moderator: William McGivney, PhD Managing Partner, McGivney Global Advisors Faculty: Marnie Kershner, CScD, CCC-SLP, BCS-S Senior Speech Pathologist, Medstar National Rehabilitation Hospital Afsaneh Barzi, MD, PhD Medical Director – GI Oncology, City of Hope Ramy Sedhom, MD Medical Oncologist and Palliative Medicine, Penn Medicine Roberto Ochoa Planchart, MD Senior Medical Officer, The Oncology Institute
9:00am - 9:50am	IRA Impact: Pharma Translating Impact Over the Next 5 Years Moderator: Lindsay Bealor Greenleaf, JD Solution Leader, Federal and State Policy, ADVI Health Faculty: Arda Ural, MBA, PhD Americas Industry Markets Leader for Life Sciences and Healthcare, Ernst & Young LLP (EY) Annette Powers, MBA, PharmD VP for Global Market Access, Bristol Myers Squibb Mark Vineis Chief Market Access Officer, Novartis Randy Burkholder VP, Policy and Research, PhRMA Cell and Gene Therapy Access – Product Cycle, CMS Model, and Patient Support Moderator: Stephanie Hobbs Principal, ECG Consultants Faculty: Jie Zhang, PhD VP, Head of Global Value and Access, Cell & Gene, Novartis Michael Wong, MD, PhD, FRCPC Professor, Department of Melanoma Medical Oncology MD Anderson Caleb DesRoisiers Pharmaceutical and Managed Care Services Executive COPILOT Provider Support Services, Inc Ross Hoffman, MD Chief Medical Officer, Centene Revenue Cycle Policy and Trends Moderator: Barbara McAneny, MD Past President, American Medical Association Chair, National Cancer Care Alliance CEO, New Mexico Cancer Center Faculty: Ron DiGiaimo, MBA, FACHE Chairman of the Board Revenue Cycle Coding Strategies Parag Shah President, Practice Solutions, Integra Connect Anne Hubbard Director, Health Policy, ASTRO How ePRO Technology Benefit Cancer Patients Moderator: Barry Russo CEO, Center for Cancer and Blood Disorders Faculty: Hillary Cavanagh Director, Division of Ambulatory Payment Models, Center for Medicare & Medicaid Innovation Brad Hirsch, MD, MBA Head of Product & Implementation, Verily Shelley Davis, MSN, RNC, CCM VP, Clinical Strategy, Lightbeam Health Solutions Madelyn Trupkin Herzfeld, RN, BSN, OCN Founder & Vice-Chairman, carevive
10:00am - 10:50am	IRA Healthcare Industry: Translating Impact Over the Next 5 Years Moderator: Jayson Slotnik, JD, MPH Partner, Health Policy Strategies Faculty: Muna Tuna US Market Pricing and Reimbursement Leader Ernest & Young, LLP Luke Greenwalt Vice President and Lead Market Access Center of Excellence, IQVIA Jeff Allen, PhD President & CEO Friends of Cancer Research Value-Based Agreements in Oncology: What Cancer Care Practices are Doing in the Marketplace Today Moderator: Michael Kolodziej, MD Senior Advisor, ADVI Health Faculty: Sibel Blau, MD President/CEO at Quality Cancer Care Alliance (QCCA) Network James Gilmore, PharmD Chief Pharmacy and Clinical Services Officer, AON Daniel Virnich, MD, MBA, FACHE CEO, The Oncology Institute Ted Okon, MBA Executive Director, COA Jeffrey Scott, MD President & Chief Medical Officer Integra Connect Josh Eaves Chief Development & Strategy Officer Florida Cancer Specialists Cell and Gene Therapy and the Future Impact on Cancer Care Moderator: Phil Cyr Senior VP, Precision Value & Health Faculty: Lung-I Cheng VP, Cell and Gene Therapy, AmerisourceBergen Paul LaPorte, MD Medical Director, The Oncology Institute Oncology Drug Shortages Moderator: Kathy Oubre, MS CEO, Pontchartrain Cancer Center Faculty: David Senior, MPH Senior VP, Market Economics, Cencora (formerly AmerisourceBergen) Gina Guinasso, JD President, CivicaScript Kevin Congdon VP, Institutional Sales, Accord Healthcare Michael Ganio, PharmD, MD, FASHP Senior Director, Pharmacy Practice and Quality, ASHP
11:00am - 11:50am	IRA Providers: Translating Impact Over the Next 5 Years Moderator: Michael Kolodziej, MD Senior Advisor, ADVI Health Faculty: Debra Pratt, MD, PhD, MBA Executive Vice President, Policy and Strategic Initiatives, Texas Oncology Ted Okon, MBA Executive Director, COA David Senior, MPH Senior VP, Market Economics Cencora (formerly AmerisourceBergen) Jeff Patton, MD CEO, OneOncology & Executive Chairman of the Board, Tennessee Oncology Disparities and the Impact on Cancer Care Moderator: Sybil Green, JD, RPh, MHA Diversity and Inclusion Officer American Society of Clinical Oncology Faculty: Ricky Martin, MD, MPH Medical Director, DI, Tennessee Oncology Joe Baffone CEO & Co-Founder, Annexus Health Edith Mitchell, MD, MACP, FCPP, FRCP (London) Clinical Professor of Medicine and Medical Oncology Department of Medical Oncology Director, Center to Eliminate Cancer Disparities Associate Director, Diversity Affairs Sidney Kimmel Cancer Center at Jefferson Member, President's Cancer Panel 116th President, National Medical Association Generative AI, Large Language Models in Personalized Medicine Moderator: Ira Klein, MD, MBA, FACP VP, Medical Affairs, Payer Relations, Tempus Labs, Inc. Faculty: Dennis Flannelly, MBA Head of Precision Medicine, Merck Michael Sherman, MD, MBA Venture Partner, RA Capital Management, L.P. Cory Wiegert COO, Integra Connect Understanding the Economics of the Oncology Drug Pricing Ecosystem Moderator: Kent Rogers, MBA Former Chief Customer Officer, EQRx; Former SVP, Industry Relations, OptumRx Faculty: Antonio Ciaccia CEO, 46brooklyn Research and 3 Axis Advisors Robert Popovian, PharmD, MS Founder, Conquest Advisors Eric Percher Senior Analyst, Pharma Supply Chain & Digital Health, Nephron
12:30pm - 1:20pm	Keynote with Scott Gottlieb, MD, Former Commissioner, FDA
1:30pm - 2:20pm	Improving the Collaboration Between Oncology Practices and the PBM Industry Moderator: Michael Kolodziej, MD Senior Advisor, ADVI Health Faculty: Lalan Wilfong, MD VP, Payer Relations and Practice Transformation, McKesson Mostafa Kamal CEO, Magellan Rx Jeff Patton, MD CEO, OneOncology & Executive Chairman of the Board, Tennessee Oncology Integrating Precision Medicine Data into Real-World Pathways and Clinical Utility Moderator: Lucio Gordan, MD Chief Medical Officer for Therapeutics and Analytics & Past President, Florida Cancer Specialists Faculty: James Hamrick, MD, MPH VP, Clinical Oncology Flatiron Health Paul LaPorte, MD Medical Director The Oncology Institute Lucy Langer, MS, MD National Medical Director Oncology and Genomics, UnitedHealthcare Succeeding in Value-Based Payment Arrangements: ASCO’s Patient Centered Cancer Care Certification Pilot Moderator: Stephen Grubbs, MD, FASCO VP, Care Delivery, American Society of Clinical Oncology Faculty: Brian Bourbeau, MBA Division Director, Practice Health, American Society of Clinical Oncology Sybil Green, JD, RPh, MHA Diversity and Inclusion Officer, American Society of Clinical Oncology Matthew Skelton, MD Medical Oncology/Hematology, Blue Ridge Cancer Care Chiara Batelli, MD Medical Oncology/Hematology, New England Cancer Specialists Oncology and Vertically Integrated Supply Channels Moderator: Doug Long VP, Industry Relations, IQVIA Faculty: Lisa Harrison, RPh SVP and President Specialty Distribution and Solutions AmerisourceBergen Anthony Pansy Executive Vice President Business Development FFF Enterprises Barry Brooks, MD, MBA Chairman P&T US Oncology Network
2:30pm - 3:20pm	Pharma’s Role and Participation in Value-Based Agreements Moderator: Basit Chaudry, MD, PhD Founder, Tuple Health Faculty: Ranjani Durham Senior VP and Head US Market Access, BMS Brian Morrissey, MBA VP, Oncology National Customer Group, Pfizer Eliott Zarrett AVP, Oncology Payer Access and Pricing, Merck Michael Valenta VP, Value, Access and Pricing Strategic Customer Group (SCG) at Johnson & Johnson Challenges in Transitioning to Value-Based Care Moderator: Jeffrey Scott, MD President & Chief Medical Officer Integra Connect Faculty: Joel White President & CEO Horizon Government Affairs Lalan Wilfong, MD VP, Payer Relations and Practice Transformation, McKesson Alti Rahman, MHA, MBA, CSSBB Chief Strategy and Innovation Officer American Oncology Network, LLC (AON) GPOs and Their Future Impact and Role in Cancer Care Moderator: Eric Percher Senior Analyst Pharma Supply Chain & Digital Health Nephron Faculty: Ginger Ertel, PharmD, MBA VP, Pharmacy Member Services, Vizient Rick Lozano SVP, Specialty GPOs, AmerisourceBergen Lisa Raff, PharmD, MSPharm, BCPS, BCOP VP, Pharmacy Services, OneOncology Jessica Daly, PharmD, MBA Group VP, Strategic Sourcing, Premier Geoffrey Snow VP, GPO Operations, McKesson Examining the Clinical, Quality and Cost Impact of Breaking Down Silos Between Medical & Pharmacy Care Moderator: Denali Cahoon, PharmD Chief Pharmacy and Operating Officer, House Rx Faculty: Joseph Leach, MD SVP & Chief Medical Officer Prime Therapeutics Wafa Samara, RPh, PharmD VP & Chief Pharmacy Officer City of Hope Joshua Cox, PharmD, BCPS Director of Pharmacy Services Dayton Physicians Network John Watson, PharmD Chief Growth Officer HealthStrategy, LLC
3:30pm - 4:20pm	Enhancing Oncology Model (EOM) Update Moderator: Michael Kolodziej, MD Senior Advisor, ADVI Health Faculty: Barbara McAneny, MD Past President, American Medical Association; Chair, National Cancer Care Alliance; CEO, New Mexico Cancer Center Lalan Wilfong, MD VP, Payer Relations and Practice Transformation, McKesson Bobby Green, MD Co-Founder, President & Chief Medical Officer, Thyme Alexandra Chong, PhD EOM Team Lead CMS Innovation Center Innovative Reimbursement Models Based on Outcomes and Services Moderator: Howard Kraft Chief Strategy and Innovation Officer, XO Health Faculty: Daniel Virnich, MD, MBA, FACHE CEO, The Oncology Institute Rhonda Henschel, MBA VP, Payer Relations, McKesson Aaron Lyss Senior Director Strategic Payer Relations OneOncology Joel Brill, MD Chief Medical Officer Predictive Health Pharma Value-Based Programs: What Worked, Failed and is the Future Moderator: Natalie Bedford Senior VP, CenterWell Specialty Pharmacy (Humana Specialty Pharmacy) Faculty: Gergana Zlateva, MPA, PhD VP & Business Unit Lead, Oncology, Patient & Health Impact, Pfizer John Fox, MD, MHA Senior Medical Director for the Americas, Market Access, Illumina John Doyle, DrPH, MPH Group Vice President, Exponent 340B Programs: Current State Moderator: Sherri Faber, RPh, MHA President & CEO, 340B Compliance Partners Faculty: Shannon Burger, CPA CEO, Cempa Community Care Ted Slafsky Publisher & CEO, 340B Report Jackson Hammond Health Care Policy Analyst The American Action Forum Andrew Brownlee Director Berkley Research Group
4:30pm - 5:20pm	EOM: Understanding Why Providers Did Not Sign on to the CMS Program Moderator: Jeffrey Scott, MD President & Chief Medical Officer Integra Connect Faculty: Debra Pratt, MD, PhD, MBA Executive Vice President, Policy and Strategic Initiatives, Texas Oncology Barbara McAneny, MD Past President, American Medical Association; Chair, National Cancer Care Alliance; CEO, New Mexico Cancer Center Jeff Patton, MD CEO, OneOncology & Executive Chairman of the Board, Tennessee Oncology Barry Russo CEO, Center for Cancer and Blood Disorders Employers and the Impact on Cancer Care Moderator: Art Taft, MBA, MEng Managing Director, Medworks Consulting, LLC Faculty: Monte Masten, MD Chief Medical Officer MarshMcLennan Agency Lisa Comerose, RN VP, Clinical Operations MarshMcLennan Agency Chris Skisak Executive Director Houston Business Coalition on Health Personalized Medicine Cancer Therapy Management Moderator: Mark Hiatt, MD, MBA, MS Chief Medical Officer, RadSite Founder & CEO, Hiatt Advisory Services Faculty: Ira Klein, MD, MBA, FACP VP, Medical Affairs Payer Relations Tempus Labs Inc Nate Wade, PharmD, MSBA, BCOP Associate Director Clinical Oncology Flatiron Health Paul LaPorte, MD Medical Director The Oncology Institute Amar Das, MD, PhD, FACMI Real World Evidence Guardant Health Jerry Mitchell, MD, MBA Director, Field Medical Oncology Foundation Medicine The Economic Realities of Cancer Site of Care Moderator: Connie Sullivan, BSPharm President & CEO, National Home Infusion Association Faculty: Lee Blansett, MBA EVP, HMP Market Access Insights John Hennessy, MBA Principal, Valuate Tory Wolff Managing Partner, Recon Strategy Pete Scruggs Founder, benefitSMART
5:20pm - 6:00pm	Beyond EOM: How does Health Equity Fit in Multi-Stakeholder Value-Based Care Partnership Moderator: Alti Rahman, MHA, MBA, CSSBB Chief Strategy and Innovation Officer American Oncology Network, LLC (AON) Faculty: John Sargent, MD Founding Partner, BroadReach Susan Sabo Wagner MSN, RN, OCN, Vice President, Clinical Innovation, American Oncology Network Barbara McAneny, MD Past President, American Medical Association; Chair, National Cancer Care Future Models of Precision Medicine Moderator: Bruce Quinn, MD, PhD Principal, Bruce Quinn Associates LLC Faculty: Ira Klein, MD, MBA, FACP VP, Medical Affairs & Payer Relations, Tempus Stan Skrzypczak, MS, MBA Managing Partner, 5Prime Life Science Consulting, Inc. Navid Alipour, JD, MBA CEO & Co-Founder, CureMatch Mark Hiatt, MD, MBA, MS Chief Medical Officer, RadSite Founder & CEO, Hiatt Advisory Services

Thursday, October 19

8:00am - 8:50am	Building the Conglomerates of Oncology Practice: Consolidation, Competition, and Care Moderator: Nick Ferreyros Managing Director Policy, Advocacy, and Communications, COA Faculty: Nathan Walcker CEO, Florida Cancer Specialists Daniel Virnich, MD, MBA, FACHE CEO, The Oncology Institute of Hope and Innovation Sibel Blau, MD President/CEO at Quality Cancer Care Alliance (QCCA) Network Jeff Patton, MD CEO, OneOncology & Executive Chairman of the Board, Tennessee Oncology Oncology Pipeline Report Moderator: Cheryl Ann Allen, MBA, BS Pharm Founding Partner, Curatio Scientia Advisors Faculty: Kelly McAuliff, PharmD, BCOP, CSP Senior Clinical Manager, Oncology/Hematology, CVS Specialty Jeffrey Bockman, PhD Expert Advisor, Oncology Head of Oncology Center of Excellence & EVP Oncology Practice Head, Lumanity Doug Long VP, Industry Relations, IQVIA Cancer Moonshot Update Moderator: Greg Simon Co-Founder, IMX Health Exchange; CEO/CFO Intelligent Medicine Acquisition Corp. (IQMD) Payers Practicing Medicine? Medical Necessity, Prior Authorization, Patient Records, and More, Oh My! Moderator: William McGivney, PhD Managing Partner, McGivney Global Advisors Faculty: Barbara McAneny, MD Past President, American Medical Association; Chair, National Cancer Vishnukamal Golla Medical Director for Value Transformation, Evolent Health Barry Brooks, MD, MBA Chairman P&T, US Oncology Network Lucy Langer, MS, MD National Medical Director Oncology and Genomics UnitedHealthcare
9:00am - 9:50am	Observations and Trends in Cancer Care Moderator: Chevon Rariy, MD Chief Health Officer, Oncology Care Partners Faculty: Doug Long VP, Industry Relations, IQVIA Bruce Pyenson, FSA, MAAA Principal, Consulting Actuary, Miiliman Artificial Intelligence and the Impact on Care Delivery Outcomes Moderator: Alti Rahman, MHA, MBA, CSSBB Chief Strategy and Innovation Officer American Oncology Network, LLC (AON) Faculty: John Sargent, MD Founding Partner at BroadReach Tony Blau President & CEO, All4Cure Cory Wiegert COO, Integra Connect Andy Corts Chief Technology Officer OneOncology Evolution of Clinical Trials Faculty: Mark Lee Co-Founder, Npower Maurie Markman City of Hope Elizabeth Garrett-Mayer, PhD VP, Center for Reasearch and Analytics, ASCO Sibel Blau, MD President/CEO at Quality Cancer Care Alliance (QCCA) Network Align & Thrive: Matching Information Exchange with Financial Flows Moderator: Jack Salerno Managing Partner, SBD Partners, LLC Faculty: Brian Gockerman CEO, Unlimited Systems Jonathan Zimmerman CEO, Holon Solutions
10:00am - 10:50am	The Battle for Oncology Margin in US Drug Channels Moderator: Doug Long VP, Industry Relations, IQVIA Faculty: Adam Fein, PhD CEO, Drug Channels Institute Establishing Value for Pharmaceuticals Moderator: William McGivney, PhD Managing Partner, McGivney Global Advisors Faculty: Annette Powers VP for Global Market Access, Bristol Myers Squibb Daniel Ollendorf, PhD, MPH Director of Value Measurement & Global Health Initiatives, Center for the Evaluation of Value and Risk in Health (CEVR); Assistant Professor, Tufts University School of Medicine Cancer Vaccines a New Treatment Paradigm Moderator: Jeffrey Bockman, PhD Expert Advisor, Oncology Head of Oncology Center of Excellence & EVP Oncology Practice Head, Lumanity The Evolution of Patient Advocacy Moderator: Elizabeth Franklin, PhD, MSW Head, US Public Affairs and Patient Advocacy, Oncology, Sanofi Faculty: Trish Goldsmith CEO, CancerCares Afsaneh Barzi, MD, PhD Medical Director – GI Oncology, City of Hope Brenda Nevidjon, MSN, RN, FAAN CEO, Oncology Nursing Society Alan Balch, PhD CEO, Patient Advocate Foundation Lisa Lacasse, MBA President, American Cancer Society Cancer Action Network
11:00am - 11:50am	The Ever-Changing Relationships Between Regional and Community in Cancer Care Moderator: Michael Kolodziej, MD Senior Advisor, ADVI Health Faculty: Nathan Walcker CEO, Florida Cancer Specialists Sibel Blau, MD President & CEO, Quality Cancer Care Alliance Network; Medical Director, Northwest Medical Specialties Tim Kubal, MBA, MD Senior Medical Director, Moffitt Cancer Center Transforming the Oncology Practice Clinically and Financially Moderator: Jeffrey Scott, MD President & Chief Medical Officer Integra Connect Faculty: Nicole Chambers VP, Strategic Initiatives Annexus Health Alti Rahman, MHA, MBA, CSSBB Chief Strategy and Innovation Officer American Oncology Network, LLC (AON) Scotty Pepper VP Operations Population Health, Integra Connect Precision Medicine’s Role Ensuring Accurate Diagnosis and Treatment Moderator: John Fox, MD, MHA Senior Medical Director for the Americas, Market Access, Illumina Faculty: Lucy Langer, MS, MD National Medical Director Oncology and Genomics, UnitedHealthcare James Hamrick, MD, MPH VP, Clinical Oncology Flatiron Health Ira Klein, MD, MBA, FACP VP, Medical Affairs Payer Relations Tempus Labs Inc. Brian Bourbeau, MBA Division Director Practice Health American Society of Clinical Oncology The Evolution of the MIP and Influences Impacting Patient Care Moderator: Michael Reff, RPh, MBA Founder & Executive Director, NCODA Faculty: Stacey McCullough, PharmD Director Clinical & Corporate Strategy NCODA Joseph Leach, MD SVP & Chief Medical Officer Prime Therapeutics Emily Gentry, RN, BSN, OCN, HON-ONN-CG Executive Director Strategy & Operations AONN+ Scott Freeswick, MS, PharmD VP & Chief Pharmacy Officer Memorial Sloan Kettering Cancer Center Brian Morrissey, MBA VP, Oncology National Customer Group, Pfizer
12:30pm - 1:20pm	Fireside Lunch – Value in Practice Moderator: Marianne Gandee VP, Patient Solutions & Alliances North America, Pfizer Oncology Faculty: Shanthi Sivendran, MD, MSCR, MBA SVP, Cancer Support American Cancer Society Alex Tabarrok, PhD Bartley J. Madden Chair in Economics Mercatus Center at George Mason University
1:30pm - 2:20pm	Payers and Future Value-Based Transformation Moderator: Michael Kolodziej, MD Senior Advisor, ADVI Health Faculty: Yale Podnos, MD Chief Medical Officer The Oncology Institute Lucy Langer, MS, MD National Medical Director Oncology and Genomics UnitedHealthcare Adam Myers, MD, MHCM, FACHE Former Chief Clinical Transformation Officer Blue Cross Blue Shield Association A View on Legislation and Policy Out of Washington Ahead Moderator: Jayson Slotnik, JD, MPH Partner, Health Policy Strategies Faculty: Nicolas Ferreyros Managing Director of Policy Advocacy, and Communications Community Oncology Alliance Jerrica Mathis, MSED Head of Federal Government Relations Cardinal Randy Burkholder VP, Policy and Research, PhRMA Shelly Mui-Lipnik, JD Head of Federal Government Relations Cencora (formerly AmerisourceBergen) Value-Based Agreements: Roadmap from Strategy to Design Through Implementation Moderator: John Doyle, DrPH, MPH Group Vice President, Exponent Faculty: Greg Gregory, PhD Vice President Managing Director PRECISIONadvisors Rhonda Henschel, MBA VP, Payer Relations, McKesson Dorothy Hoffman, MPP Executive Director Head of Global Immunology Policy Novartis Michael Lynch, CPA, MBA Head of Market Access Strategy Bayer Radiology Division The Essential to Achieving Success in Value-Based Care: Medically Integrated Pharmacies & Dispensaries Moderator: Tesh Khullar, MBA Co-Founder & President, HouseRxx Faculty: Aaron Lyss Senior Director Strategic Payer Relations OneOncology Alti Rahman, MHA, MBA, CSSBB Chief Strategy and Innovation Officer American Oncology Network, LLC (AON) Marci Conlin VP, Pharmacy Network Management Prime Therapeutics Sibel Blau, MD President/CEO at Quality Cancer Care Alliance (QCCA) Network
2:30pm - 3:20pm	IRA and the Regulator’s Role in Price Negotiations Faculty: Marianne Hamilton Lopez, PhD, MPA Duke Margolis Center for Policy, Duke University Daniel Ollendorf, PhD, MPH Director of Value Measurement & Global Health Initiatives, Center for the Evaluation of Value and Risk in Health (CEVR); Assistant Professor, Tufts University School of Medicine Healthcare Interoperability: Advancing the Data State of Play in Value-Based Oncology Care Moderator: Joel Brill, MD Chief Medical Officer, Predictive Health Faculty: Drew Ivan Chief Product & Strategy Officer, Rhapsody Kimberly Chaundy, MBA Associate Vice President Applications & Interoperability, Geisinger Brad Ryan Chief Growth Officer, NCQA Charlie Harp CEO, Clinical Architecture Biosimilars and Industry Observations: Future Sustainability Faculty: Harsher Singh, MBA SVP, Amneal Pharmaceuticals Lisa Raff, PharmD, MSPharm, BCPS, BCOP VP, Pharmacy Services OneOncology Neal Lambert Senior Director & Team Lead Pricing Strategy US Biosimilars, Pfizer Barry Brooks, MD, MBA Chairman P&T US Oncology Network
3:30pm - 4:20pm	Creating Collaborative Partnerships: Stakeholder Perspectives Between Pharma, Payers, and Providers Moderator: Rani Khetarpal, MBA VP, Strategic Partnerships, Moderna Faculty: Samyukta Mullangi, MD, MBA, MS Medical Oncology Director, Thyme Care Ranjani Durham Senior Vice President and Head, US Market Access, BMS Jeff Davis Executive Director National Channel, AstraZeneca Afsaneh Barzi, MD, PhD Medical Director – GI Oncology, City of Hope Unified Leadership Efforts to Address and Shape the Future of Cancer Care Moderator: Cliff Hudis, MD, FACP, FASCO CEO, ASCO Faculty: Nicolas Ferreyros Managing Director of Policy, Advocacy, and Communications, Community Oncology Alliance Alyssa Schatz Senior Director Policy & Advocacy, NCCN New Patient-Centric Cancer Care Models Moderator: Chevon Rariy, MD Chief Health Officer, Oncology Care Partners Faculty: Greg Orr, MBA Chief Operating Officer, Jasper Health Andrew Norden, MD, MPH, MBA Chief Medical Officer, OncoHealth Bobby Green, MD Co-Founder, President & Chief Medical Officer, Thyme Kent Locklear, MD Chief Medical Officer Lightbeam Health Solutions Pediatrics and Cancer Care Moderator: Jon Hamrick Partner, Curatio Scientia Advisors Faculty: Robyn Gartrell, MD Assistant Professor of Pediatrics, CUMC Andrew Kung, MD, PhD Chair of Pediatrics Memorial Sloan Kettering Cancer Center Stephen Speicher, MD, MS Head of Care Quality Flatiron Health Stan Skrzypczak, MS, MBA Managing Partner 5Prime Life Science Consulting, Inc.
4:30pm - 5:20pm	Good and Bad: Washington and State Policy and Economics Impacting Healthcare Moderator: Jayson Slotnik, JD, MPH Partner, Health Policy Stategies Faculty: Joe Grogan, JD Fellow, USC Schaeffer Center; Former Assistant to the President, Director of the Domestic Policy Council Capital Markets View on Pharmaceutical Innovation and Value Moderator: Ipsita Smolinski, MBA, MPH Founder & Managing Director, Capitol Street Navigating Payer Complexities in Oncology Coverage, Impact of Value Contracting & Ensuring Providers Understand Patient Access Implications Moderator: Charles Stevens, JD, MBA CEO, COPILOT Provider Support Services Faculty: John Hennessy, MBA Principal, Valuate Health Consultancy Susan Raiola President, Real Endpoints David Schmidt Head of US Growth, RxPx Sumner Madden Executive Director US Patient Support AstraZeneca Ela Lourido, MBA VP and General Manager Specialty Pharmacy Solutions Transparent PBM Models Moderator: Bob Charles, MBA Independent Strategy Consultant Faculty: Ethan Davidoff Founder & CEO Atlas Health Greg Baker, RPh CEO, AffirmedRx Sunil Budhrani, MD Chief Innovation & Medical Officer CapitalRx John Watson, PharmD Chief Growth Officer HealthStrategy, LLC
5:20pm - 6:00pm	Cancer Research and the Road Ahead Moderator: Rob Butcher President & CEO, Swim Across America Faculty: Steven Rosen, MD, FACP, FASCO, FAIMBE Provost and Chief Scientific Officer, City of Hope Jedd Wolchok, MD, PhD, FASCO Meyer Director of the Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine Sam Urrutia, MD MD Anderson Nancy Daly, MS, MPH CEO, Conquer Cancer Mike Foote, MD Gastrointestinal Oncologist Memorial Sloan Kettering Cancer Center
6:00pm - 9:00pm	Reception Honoring Swim Across America surpassing the $120m Funding Ceiling for Cancer Research in 2023

Friday, October 20

8:00am - 8:50am	Practice Transformation Through Value-Based Analytics Moderator: Nina Chavez, MBA, FACHE VP, Customer Experience, Flatiron Health Faculty: Lalan Wilfong, MD VP, Payer Relations and Practice Transformation, McKesson Basit Chaudhry, MD, PhD Founder, Tuple Health Yale Podnos, MD, MPH, FACS Chief Medical Officer, The Oncology Institute of Hope and Innovation Jeffrey Scott, MD President & Chief Medical Officer Integra Connect Financial Toxicity Moderator: Angie Santiago Thomas Jefferson University Hospital & ACCC Financial Advocacy Network Chair Faculty: Lori Schneider Green Bay Oncology & ACCC Financial Advocacy Network Advisory Committee, Board of Trustee Member ACCC Rifeta Kajdic-Hodzic Oncology Education Program Manager at Association of Community Cancer Centers Clorinda Walley President, Happy Days The Impact of Inflation on the Healthcare Ecosystem Moderator: Chevon Rariy, MD Chief Health Officer, Oncology Care Partners Faculty: Thom Bales Principal, PricewaterhouseCoopers Advisory, LLC
9:00am - 9:50am	Primary Care Risk-Sharing Agreements with Specialty Cancer Care Moderator: Jeffrey Scott, MD President & Chief Medical Officer Integra Connect Faculty: Casey Rhode SVP, OneOncology Lalan Wilfong, MD VP, Payer Relations and Practice Transformation, McKesson Tim Barry Co-Founder & CEO VillageMD Daniel Virnich, MD, MBA, FACHE CEO The Oncology Institute Joel Brill, MD Chief Medical Officer Predictive Health Unlocking Innovation in Value-Based Care: Reflections on Current Policy Efforts Surrounding PBMs & Where Regulators Should Focus Next Moderator: Allison Canton, JD General Counsel, House Rx Faculty: Nicolas Ferreyros Managing Director of Policy Advocacy, and Communications Community Oncology Alliance Barbara McAneny, MD Past President American Medical Association Chair, National Cancer Care Alliance CEO, New Mexico Cancer Center Barry Brooks, MD, MBA Chairman P&T US Oncology Network Deborah Kamin, PhD, Rn VP, Policy & Advocacy, ASCO Specialty Oncology Pharmacy Networks Moderator: Bhavesh Shah, RPh, BCOP Chief Pharmacy Officer, Hematology/Oncology and Specialty Pharmacy, Boston Medical Center Faculty: Jorge Garcia, PharmD, MS, MHA, FACHE Assistant VP, System Oncology Pharmacy Service Line, Baptist Health South Florida Yen Nguyen, PharmD Executive Director of Pharmacy, Oncology Consultants Christie Smith, PharmD, MBA Senior Director, Payer Initiatives, Oncology Supply, an AmerisourceBergen Company Benito Fernandez MBA Chief Commercial Officer Onco360 Crystal Lennartz, PharmD VP & GM McKesson Marci Conlin VP, Pharmacy Network Management Prime Therapeutics A Holistic Overview on the Real Cost of Cancer on Patients Moderator: Richard Brook President, Better Health Worldwide, Inc. Faculty: Chester ("Bernie") Good, MD, MPH Senior Medical Director Center for Value-Based Pharmacy Initiatives at UPMC Health Plan Davida Silverman Director, Oncology Public Policy & Reimbursement, Genentech
10:00am - 10:50am	Clinician Leadership Role in Transforming Cancer Care Moderator: David Johnson, MD, MPH Clinical Operating Partner, Rubicon Founders Faculty: Paul LaPorte, MD Medical Director The Oncology Institute Marcus Neubauer, MD Chief Medical Officer US Oncology AI and ML Decision Support Models Moderator: James Hamrick, MD, MPH VP, Clinical Oncology, Flatiron Health Faculty: Susan Weidner SVP Intrinsiq Specialty Solutions Jeffrey Becker, MBA VP, Business Development PRECISIONxtract Sagran Moodley Chief innovation Officer & Technology Officer, Ontada Surgical Oncology and the Impact and Role in Value-Based Agreements Moderator: Lawrence Wagman MD, FACS Clinical Professor, Div. Surgical Oncology, City of Hope Faculty: Yale Podnos, MD, MPH, FACS Chief Medical Officer, President of Practice, The Oncology Institute of Hope and Innovation Proactive Financial Assistance Moderator: Kathy Oubre, MS CEO, Pontchartrain Cancer Center Faculty: Niobis Queiro President & CEO, The Queiro Group Trish Goldsmith CEO, CancerCares Nick Jaidar, MHA, FACHE Director of Oncology Operations and Faculty Practice Administrator University of Maryland Greenbaum Comprehensive Cancer Center Tim L'Hommedieu, PharmD Senior Vice President Atlas Health
11:00am - 11:50am	Rise of MA Health Plan and Impact on Cancer Care Moderator: Jayson Slotnik, JD, MPH Partner, Health Policy Strategies Faculty: Hiram Satterwhite, FSA, CERA, MAAA Senior Consulting Actuary Milliman Ross Hoffman, MD Chief Medical Officer Centene How Do I Handle Bundle Payments Moderator: Barry Russo CEO, Center for Cancer and Blood Disorders Faculty: Lalan Wilfong, MD VP, Payer Relations and Practice Transformation, McKesson Alti Rahman, MHA, MBA, CSSBB Chief Strategy and Innovation Officer American Oncology Network, LLC (AON) Radiation Oncology: A New Approach and Model Moderator: Jordan Johnson, MSHA, iMpaCT Chief Innovation Officer, Oncospark Faculty: Arprit Chhabra, MD Director Education & Radiation Oncologist New York Proton Center Cheryl Turner. EdD, RT (R )(T) Director of Global Education & Training Legion Healthcare Partners Al Lawson, PhD SVP, Radiation Oncology Tennessee Oncology Jacob Philip CEO, MedLEver Join Luh, MD, FACP, FACR Radiation Oncologist Providence Health
12:00pm - 12:50pm	A Case for Sustaining Navigation the Economic Value and Metrics Behind Improving Outcomes and Quality of Life Moderator: Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN Program Director, Academy of Oncology Nurse & Patient Navigators Faculty: Andi Dwyer, BS Program Director Colorado Cancer Screening Program Tricia Strusowski, MS, RN CEO & Co-Founder TurnKey Oncology Steven Peskin, MD, MBA, MACP Former Executive Medical Director Population Health and Transformation Horizon BCBS Addressing the Uncertainty of Cell and Gene Therapy’s Durability of Response through Novel Financing Arrangements Moderator: Joe DePinto Head of Cell, Gene & Advanced Therapies, McKesson Faculty: Herman Sanchez, MBA Chief Business Officer, Trinity Life Sciences Carlos Martin, MBA Chief Commercial Officer & Head of International, Rocket Pharma Chester Good, MD, MPH Senior Medical Director Center for Value-Based Pharmacy Initiatives at UPMC Health Plan Personalized Medicine Moderator: Van Crocker, MBA President, Agonist Health Faculty: Dorothy Hoffman, MPP Executive Director Head of Global Immunology Policy Novartis Carolyn Magill, MBA CEO, Aetion Viraj Narayanan, MBA Chief Commercial Officer, Ontada Todd Johnson, MD Chief Growth Officer Aster Insights (formerly M2Gen) Drug/Biologic Development; To Market; To Out-License; To be Acquired Moderator: William McGivney, PhD Managing Partner, McGivney Global Advisors Faculty: Pat Fetaya Head of US Business Development Servier Alex Santini SVP & Head, Global and US Market Access Arvinas Inc. Vicki Vakiener Board of Director Member Arrowhead Pharmaceuticals
1:00pm - 1:50pm	The Rise of Concierge Benefit Managers and Impact on Cancer Care Moderator: Lalan Wilfong, MD VP, Payer Relations and Practice Transformation, McKesson Faculty: Dickon Waterfield Chief Commercial Officer, Employee Direct Healthcare The Voice and Rights of a Patient with Cancer Moderator: Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN Program Director, Academy of Oncology Nurse & Patient Navigators Faculty: Lisa Lacasse, MBA President American Cancer Society Cancer Action Network Molly Bognar, MSN, RN Head of Clinical Jasper Health Addressing Burnout in the Oncology Industry Faculty: Liudmila Schafer, MD, FACP Medical Oncologist, Medical Oncologist, Mercy Health System St Louis Radiation Oncology: Under Clinical Pathways, Transparency, and with Risk Share Moderator: Jordan Johnson, MSHA, iMpaCT Chief Innovation Officer, Oncospark Faculty: Arprit Chhabra, MD Director Education & Radiation Oncologist New York Proton Center Cheryl Turner. EdD, RT (R )(T) Director of Global Education & Training Legion Healthcare Partners Al Lawson, PhD SVP, Radiation Oncology Tennessee Oncology Jacob Philip CEO, MedLEver

*Agenda subject to change. Additional faculty to be announced.

Location

New York Athletic Club
180 Central Park South, New York, NY 10019

Hotels

Park Lane Hotel New York

36 Central Park South
New York, NY 10019

Hilton Garden Inn Central Park

237 West 54th Street
New York, NY 10019

Park Central Hotel

870 Seventh Avenue At 56th Street
New York, NY 10019

Fairfield Inn N Stes Marriott

538 W. 58th Street
New York, NY 10019

Please Note: There are no lodging accommodations at the New York Athletic Club.

AVBCC is excited to offer discounted room rates this year!
Click Here for AVBCC Accommodations
Transit Information
SUBWAY LINES

W – N – Q – W

A, C, or 1 train to 59th Street – Columbus Circle

NEAREST SUBWAY STATION

57 Street Subway Station (7th Avenue & 57th Street)

PARKING

GMC: 200 Central Park South (59th Street & 7th Avenue)

Icon Parking System: 125 West 58th Street (58th Street & 7th Avenue)

Icon Parking System: 157 West 57th Street (57th Street & 7th Avenue)
Dress Code
MEN

Business attire; jackets and ties are not required in most areas.

Slacks or khakis are permitted with collared dress shirts, which must be tucked in at all times.

Jackets and ties are required in the Main Dining Room and Cocktail Lounge.

WOMEN

Suits, dresses, sweaters, blouses, skirts, and tailored pants are permitted.

Halter tops, leggings, and clothing that reveals midriffs remain prohibited.

NOT PERMITTED (Men & Women)

Sneakers, athletic shoes, flip-flops, clogs, and canvas boating shoes.

Jeans and other denim wear, shorts, T-shirts, and athletic wear.
Mobile Voice and Data Policy

Mobile phones and devices are prohibited in all facilities of the Club except guest rooms, enclosed phone booths, and the Lobby Communication Center. This includes speaking on a cell phone, e-mailing, texting, games, reading, and Internet browsing on a mobile device. Conference attendees may use their device in the conference meeting space.
How to Sponsor the 2023 AVBCC Summit

Sponsoring the AVBCC annual summit will provide you with the opportunity to identify qualified leads on the spot, build and develop business relationships, and have unprecedented networking opportunities.

If you are interested in sponsoring the 2023 AVBCC Summit, please click the button below and submit an application by completing the form. Thank you.

AVBCC Summit Sponsorship Application
Who Should Sponsor?

All Stakeholders in the Cancer Care Ecosystem

Oncologists and Hematologists

Nurses

Oncology Nurse Navigators

Pathologists and Geneticists

Pharmacists, Practice Administrators

Practice Managers

Patient Advocacy Organizations

Managed Care Organizations

Insurance Companies

Third-Party Payers

Integrated Health Delivery Systems

Cancer Centers of Excellence

Medical Directors, Pharmacy Directors

Investors, Pharmaceutical and Biotech
Reasons Your Company Should Sponsor

Meet with decision makers from leading oncology institutions and payer organizations

Demonstrate innovative products and services

Position your company as an industry leader

Gain exposure to strategic decision makers

Expand business opportunities with existing customers

Establish strategic partnerships
2023 AVBCC Summit Sponsorship Application

Please fill out the application form below in it's entirety, then click the submit button.

*First Name
*Last Name
*Credentials
*E-mail Address
Phone Number
*Which of the following best describes your primary job title/role?
*Company/Organization
Comments
SPAM Check, leave blank
2023 AVBCC Summit FAQs

When and where will the 2023 AVBCC Summit take place?

The 2023 AVBCC Summit will take place on October 18-20, 2023 in person at the New York Athletic Club (NYAC) in New York, NY, with a virtual simulcast.

Where can I find the schedule of events?

Please see the Full Agenda, located here.

Note the agenda is subject to change, please check back for updates.

How can I register for the Summit?

The in-person event in NYAC is on a first come, first served basis due to limited capacity per state guidelines. To register for the Summit, please visit the Overview tab to request your invite.

How can I sponsor the Summit?

If you are interested in sponsoring the event, please complete the sponsor information form on the Sponsors tab.

How can I receive Summit updates?

AVBCC will send e-mails periodically to update you on the agenda, event happenings, logistics and newsletters. Please make sure that the e-mail address, This email address is being protected from spambots. You need JavaScript enabled to view it., is in your safe senders list to ensure you are receiving all important information.

Return to Top

The One Conference That Covers It All

Top Reasons to Participate in the 2023 Summit

Registration

Wednesday, October 18

The Future of Value-Based Care and Implications for US Healthcare

Moderator:

Faculty:

Digital Healthcare Technology: A Robust Growth Sector

Moderator:

Faculty:

Warranties and Reinsurance to Manage Risk: Pharma and Provider Solutions

Moderator:

Faculty:

End of Life: Have We Made Improvements to this Legacy Issue?

Moderator:

Faculty:

IRA Impact: Pharma Translating Impact Over the Next 5 Years

Moderator:

Faculty:

Cell and Gene Therapy Access – Product Cycle, CMS Model, and Patient Support

Moderator:

Faculty:

Revenue Cycle Policy and Trends

Moderator:

Faculty:

How ePRO Technology Benefit Cancer Patients

Moderator:

Faculty:

IRA Healthcare Industry: Translating Impact Over the Next 5 Years

Moderator:

Faculty:

Value-Based Agreements in Oncology: What Cancer Care Practices are Doing in the Marketplace Today

Moderator:

Faculty:

Cell and Gene Therapy and the Future Impact on Cancer Care

Moderator:

Faculty:

Oncology Drug Shortages

Moderator:

Faculty:

IRA Providers: Translating Impact Over the Next 5 Years

Moderator:

Faculty:

Disparities and the Impact on Cancer Care

Moderator:

Faculty:

Generative AI, Large Language Models in Personalized Medicine

Moderator:

Faculty:

Understanding the Economics of the Oncology Drug Pricing Ecosystem

Moderator:

Faculty:

Keynote with Scott Gottlieb, MD, Former Commissioner, FDA

Improving the Collaboration Between Oncology Practices and the PBM Industry

Moderator:

Faculty:

Integrating Precision Medicine Data into Real-World Pathways and Clinical Utility

Moderator:

Faculty:

Succeeding in Value-Based Payment Arrangements: ASCO’s Patient Centered Cancer Care Certification Pilot

Moderator:

Faculty:

Oncology and Vertically Integrated Supply Channels

Moderator:

Faculty:

Pharma’s Role and Participation in Value-Based Agreements

Moderator:

Faculty:

Challenges in Transitioning to Value-Based Care

Moderator:

Faculty:

GPOs and Their Future Impact and Role in Cancer Care

Moderator:

Faculty:

Examining the Clinical, Quality and Cost Impact of Breaking Down Silos Between Medical & Pharmacy Care

Moderator:

Faculty:

Enhancing Oncology Model (EOM) Update

Moderator:

Faculty: